63 related articles for article (PubMed ID: 15081028)
21. Synthesis and antitumor evaluation of novel 5-substituted-4-hydroxy-8-nitroquinazolines as EGFR signaling-targeted inhibitors.
Jin Y; Li HY; Lin LP; Tan J; Ding J; Luo X; Long YQ
Bioorg Med Chem; 2005 Oct; 13(19):5613-22. PubMed ID: 15993078
[TBL] [Abstract][Full Text] [Related]
22. Discovering novel 3-nitroquinolines as a new class of anticancer agents.
Li HH; Huang H; Zhang XH; Luo XM; Lin LP; Jiang HL; Ding J; Chen KX; Liu H
Acta Pharmacol Sin; 2008 Dec; 29(12):1529-38. PubMed ID: 19026174
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line.
Schenone S; Bruno O; Bondavalli F; Ranise A; Mosti L; Menozzi G; Fossa P; Donnini S; Santoro A; Ziche M; Manetti F; Botta M
Eur J Med Chem; 2004 Nov; 39(11):939-46. PubMed ID: 15501543
[TBL] [Abstract][Full Text] [Related]
24. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
Liu Y; Poon RT; Shao W; Sun X; Chen H; Kok TW; Fan ST
Cancer Lett; 2007 Apr; 248(1):32-40. PubMed ID: 16837130
[TBL] [Abstract][Full Text] [Related]
25. In silico identification of novel EGFR inhibitors with antiproliferative activity against cancer cells.
Cavasotto CN; Ortiz MA; Abagyan RA; Piedrafita FJ
Bioorg Med Chem Lett; 2006 Apr; 16(7):1969-74. PubMed ID: 16413185
[TBL] [Abstract][Full Text] [Related]
26. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
Kim SH; Song YC; Kim SH; Jo H; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
[TBL] [Abstract][Full Text] [Related]
27. N1-substituted benzamidines: synthesis, antiproteinase activity and inhibition of tumor cell growth.
Ferroni R; Simoni D; Binato G; Nastruzzi C; Manfredini S; Orlandini P; Feriotto G; Gambari R
Farmaco; 1991 Nov; 46(11):1311-21. PubMed ID: 1811617
[TBL] [Abstract][Full Text] [Related]
28. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.
Thomas SM; Bhola NE; Zhang Q; Contrucci SC; Wentzel AL; Freilino ML; Gooding WE; Siegfried JM; Chan DC; Grandis JR
Cancer Res; 2006 Dec; 66(24):11831-9. PubMed ID: 17178880
[TBL] [Abstract][Full Text] [Related]
29. S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity.
Murillo-Carretero M; Torroglosa A; Castro C; Villalobo A; Estrada C
Free Radic Biol Med; 2009 Feb; 46(4):471-9. PubMed ID: 19056486
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and inhibitory activity of 4-alkynyl and 4-alkenylquinazolines: identification of new scaffolds for potent EGFR tyrosine kinase inhibitors.
Kitano Y; Suzuki T; Kawahara E; Yamazaki T
Bioorg Med Chem Lett; 2007 Nov; 17(21):5863-7. PubMed ID: 17869510
[TBL] [Abstract][Full Text] [Related]
31. Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer.
Shaul M; Abourbeh G; Jacobson O; Rozen Y; Laky D; Levitzki A; Mishani E
Bioorg Med Chem; 2004 Jul; 12(13):3421-9. PubMed ID: 15186828
[TBL] [Abstract][Full Text] [Related]
32. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
Takeuchi K; Shin-ya T; Nishio K; Ito F
FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
[TBL] [Abstract][Full Text] [Related]
33. Tricyclic azepine derivatives: pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors.
Smith L; Piatnitski EL; Kiselyov AS; Ouyang X; Chen X; Burdzovic-Wizemann S; Xu Y; Pan W; Chen X; Wang Y; Rosler RL; Patel SN; Chiang HH; Milligan DL; Columbus J; Wong WC; Doody JF; Hadari YR
Bioorg Med Chem Lett; 2006 Mar; 16(6):1643-6. PubMed ID: 16412636
[TBL] [Abstract][Full Text] [Related]
34. Design of chimeric histone deacetylase- and tyrosine kinase-inhibitors: a series of imatinib hybrides as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-Rbeta, and histone deacetylases.
Mahboobi S; Dove S; Sellmer A; Winkler M; Eichhorn E; Pongratz H; Ciossek T; Baer T; Maier T; Beckers T
J Med Chem; 2009 Apr; 52(8):2265-79. PubMed ID: 19301902
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of half-mustard combi-molecules with fluorescence properties: correlation with EGFR status.
Rachid Z; Brahimi F; Domarkas J; Jean-Claude BJ
Bioorg Med Chem Lett; 2005 Feb; 15(4):1135-8. PubMed ID: 15686928
[TBL] [Abstract][Full Text] [Related]
36. Acryloylamino-salicylanilides as EGFR PTK inhibitors.
Deng W; Guo Z; Guo Y; Feng Z; Jiang Y; Chu F
Bioorg Med Chem Lett; 2006 Jan; 16(2):469-72. PubMed ID: 16275081
[TBL] [Abstract][Full Text] [Related]
37. Syntheses and EGFR kinase inhibitory activity of 6-substituted-4-anilino [1,7] and [1,8] naphthyridine-3-carbonitriles.
Wissner A; Hamann PR; Nilakantan R; Greenberger LM; Ye F; Rapuano TA; Loganzo F
Bioorg Med Chem Lett; 2004 Mar; 14(6):1411-6. PubMed ID: 15006373
[TBL] [Abstract][Full Text] [Related]
38. Novel bisbenzamidines and bisbenzimidazolines as noncompetitive NMDA receptor antagonists.
Tao B; Huang TL; Sharma TA; Reynolds IJ; Donkor IO
Bioorg Med Chem Lett; 1999 May; 9(9):1299-304. PubMed ID: 10340618
[TBL] [Abstract][Full Text] [Related]
39. Bisbenzamidines as antifungal agents. are both amidine functions required to observe an anti-Pneumocystis carinii activity?
Laurent J; Stanicki D; Huang TL; Dei-Cas E; Pottier M; Aliouat el M; Vanden Eynde JJ
Molecules; 2010 Jun; 15(6):4283-93. PubMed ID: 20657441
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of benzamidine derivatives as inhibitors of clotting enzymes.
Wagner G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):67-74. PubMed ID: 6177610
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]